NSAIDS and selective COX-2 inhibitors: competition between gastroprotection and cardioprotection

Lancet. 2001 Apr 21;357(9264):1222-3. doi: 10.1016/S0140-6736(00)04451-2.
No abstract available

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Anti-Ulcer Agents / therapeutic use
  • Cardiovascular Diseases / prevention & control*
  • Celecoxib
  • Cyclooxygenase Inhibitors / therapeutic use*
  • Drug Interactions
  • Humans
  • Misoprostol / therapeutic use
  • Pyrazoles
  • Stomach Diseases / chemically induced*
  • Stomach Diseases / drug therapy*
  • Sulfonamides / adverse effects*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Anti-Ulcer Agents
  • Cyclooxygenase Inhibitors
  • Pyrazoles
  • Sulfonamides
  • Misoprostol
  • Celecoxib